In the heart, PDE1A acts through regulation of cGMP levels [55], and PDE1 inhibition improved proteasomal degradation of a misfolded protein in a mouse model of proteinopathy-induced cardiac failure [56], but we do not yet know whether this may be similarly useful in HD models. This evidence concerns the gene PDE1A and Huntington disease.